Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1998 1
2001 1
2004 1
2005 3
2007 2
2008 5
2009 4
2010 2
2011 1
2012 1
2014 1
2020 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Income and Other Contributors to Poor Outcomes in U.S. Patients with Sarcoidosis.
Harper LJ, Gerke AK, Wang XF, Ribeiro Neto ML, Baughman RP, Beyer K, Drent M, Judson MA, Maier LA, Serchuck L, Singh N, Culver DA. Harper LJ, et al. Among authors: serchuck l. Am J Respir Crit Care Med. 2020 Apr 15;201(8):955-964. doi: 10.1164/rccm.201906-1250OC. Am J Respir Crit Care Med. 2020. PMID: 31825646 Free PMC article.
Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide registry study.
Alzghoul BN, Amer FN, Barb D, Innabi A, Mardini MT, Bai C, Alzghoul B, Al-Hakim T, Singh N, Buchanan M, Serchuck L, Gomez Manjarres D, Woodmansee WW, Maier LA, Patel DC. Alzghoul BN, et al. Among authors: serchuck l. ERJ Open Res. 2021 Mar 29;7(1):00754-2020. doi: 10.1183/23120541.00754-2020. eCollection 2021 Jan. ERJ Open Res. 2021. PMID: 33816601 Free PMC article.
Cohort Profile: NICHD International Site Development Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries.
Hazra R, Stoszek SK, Freimanis Hance L, Pinto J, Marques H, Peixoto M, Alarcon J, Mussi-Pinhata M, Serchuck L; NISDI Pediatric Study Group 2008. Hazra R, et al. Among authors: serchuck l. Int J Epidemiol. 2009 Oct;38(5):1207-14. doi: 10.1093/ije/dyn239. Epub 2008 Nov 26. Int J Epidemiol. 2009. PMID: 19036797 Free PMC article. No abstract available.
Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacy.
Chadwick EG, Pinto J, Yogev R, Alvero CG, Hughes MD, Palumbo P, Robbins B, Hazra R, Serchuck L, Heckman BE, Purdue L, Browning R, Luzuriaga K, Rodman J, Capparelli E; International Maternal Pediatric Adolescent Clinical Trials Group (IMPAACT) P1030 Team. Chadwick EG, et al. Among authors: serchuck l. Pediatr Infect Dis J. 2009 Mar;28(3):215-9. doi: 10.1097/INF.0b013e31818cc053. Pediatr Infect Dis J. 2009. PMID: 19209098 Free PMC article. Clinical Trial.
Pharmacokinetics of high-dose lopinavir-ritonavir with and without saquinavir or nonnucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected pediatric and adolescent patients previously treated with protease inhibitors.
Robbins BL, Capparelli EV, Chadwick EG, Yogev R, Serchuck L, Worrell C, Smith ME, Alvero C, Fenton T, Heckman B, Pelton SI, Aldrovandi G, Borkowsky W, Rodman J, Havens PL; PACTG 1038 Team. Robbins BL, et al. Among authors: serchuck l. Antimicrob Agents Chemother. 2008 Sep;52(9):3276-83. doi: 10.1128/AAC.00224-08. Epub 2008 Jul 14. Antimicrob Agents Chemother. 2008. PMID: 18625762 Free PMC article. Clinical Trial.
22 results